DavidS.GoldfarbMD
Nephrology • New York, NYDirector, Kidney Stone Prevention Program and Professor of Medicine & Physiology, NYU Grossman School of Medicine
Dr. Goldfarb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
222 East 41st Street
11th Floor
New York, NY 10017- Is this information wrong?
Summary
- Dr. David Goldfarb is a nephrologist in New York, NY and is affiliated with VA NY Harbor Healthcare System, Manhattan Campus and NYU Langone Hospitals. He received his medical degree from Yale University School of Medicine and has been in practice 36 years. He is experienced in cystinuria, medullary sponge kidney, nephrolithiasis, Dent disease, CKD, ESKD, COVID-19 and gout.
Education & Training
NYU Grossman School of MedicineFellowship, Nephrology, 1985 - 1987- NYU Grossman School of Medicine (Veterans)Residency, Internal Medicine, 1981 - 1985
Yale School of MedicineClass of 1981
Certifications & Licensure
NY State Medical License 1983 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow (FASN) American Society of Nephrology
- Fellow, NKF National Kidney Foundation, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- The Effects of Sports Drinks on Urinary Lithogenicity Start of enrollment: 2006 Mar 01
- Rare Kidney Stone Consortium Patient Registry Start of enrollment: 2003 Jul 01
- Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers Start of enrollment: 2009 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsComparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.Ryan S Hsi, Phyllis L Yan, Joseph J Crivelli, David S Goldfarb, Vahakn Shahinian, John M Hollingsworth> ;Urology. 2022 May 8
- 14 citationsCystinuria: an update on pathophysiology, genetics, and clinical managementViola D’Ambrosio, Giovanna Capolongo, David S. Goldfarb, Giovanni Gambaro, Pietro Manuel Ferraro> ;Pediatric Nephrology. 2021 Nov 23
- 1 citationsRecommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning.Marc Ghannoum, Ingrid Berling, Valery Lavergne, Darren M. Roberts, Taís Freire Galvão, Robert S. Hoffman, Thomas D. Nolin, Andrew Lewington, Kent Doi, Sophie Gosselin,...> ;Kidney International. 2021 Oct 1
- Join now to see all
Other
- Opioid Overuse or NSAID Underuse? A Response to the Pain GuideDavid Goldfarb, MD, American Journal of Kidney Diseases
https://www.doximity.com/articles/f5536f97-56ab-4efb-8c6e-3feb55264fa5
UpToDate, Wolters Kluwer Health - 2012-05-15
Press Mentions
Removal of Small, Asymptomatic Kidney Stones Cuts Relapse RiskAugust 12th, 2022- Removal of Small Asymptomatic Kidney Stones Significantly Reduces Recurrence -News ForestAugust 10th, 2022
- Removing Small Asymptomatic Kidney Stones Significantly Reduces RecurrenceAugust 10th, 2022
- Join now to see all
Grant Support
- CystinuriaNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Committees
- Vice-chair, American Urological Association, Medical Management of Kidney Stones 2013 - 2014
Professional Memberships
- Fellow
- Member
- Member
Hospital Affiliations
NYU Langone HospitalsNew York, New York- Veterans Affairs New York Harbor Healthcare System - New York CampusNew York, New York
Industry Relationships
- Consultant, Travere2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
